pic1The Brain Tumor Nanotechnology Lab is led by Constantinos Hadjipanayis, MD, PhD, Professor and Site Chair of Neurosurgery, Director of Neurosurgical Oncology, and Professor of Oncological Sciences at the Icahn School of Medicine of the Mount Sinai Medical Center. Dr. Hadjipanayis is also a Georgia Cancer Coalition Distinguished Scholar, and serves as the President of the Southeastern Brain Tumor Foundation.

Dr. Hadjipanayis’s research interests involve pioneering treatments and imaging for patients with malignant brain tumors. He is the director of the Brain Tumor Nanotechnology Laboratory and principle investigator on clinical trials for patients with malignant brain tumors, as well as an active member of the Radiation Therapy Oncology Group (RTOG) and the Adult Brain Tumor Consortium (ABTC).

Dr. Hadjipanayis specializes in surgical neuro-oncology (surgery of the brain and spine) and the development of novel therapeutics for brain tumors. He performs delicate operations specializing in the removal of brain tumors (cancerous and non-cancerous), skull base tumors, spinal tumors and experimental treatments for malignant tumors. Dr. Hadjipanayis specializes in minimally-invasive neuro-endoscopic procedures to treat disorders in the brain and endoscopic procedures for the removal of skull base tumors through the nose. He was the only neurosurgeon in Georgia performing neuroendoscopic resection of colloid cyst brain tumors.

MD, Jefferson Medical College of Thomas Jefferson University
PhD, University of Pittsburgh, Dept. of Molecular Genetics and Biochemistry
Residency in neurosurgery, University of Pittsburgh School of Medicine               Fellowship in neurosurgical oncology, University of California, San Francisco